TFSA Investors: 3 Cheap Growth Stocks to Buy Right Now

Given their high-growth prospects and attractive valuations, these three growth stocks would be excellent additions to your TFSA.

| More on:
Upwards momentum

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

This year, growth stocks are under pressure amid concerns over their higher valuation, increasing interest rate, and expectation of a slowdown in growth prospects. However, the correction has presented an excellent entry point for long-term investors in some quality stocks. Meanwhile, here are my three top picks, which you can invest through your TFSA (Tax-Free Savings Account) to maximize your returns.

WELL Health Technologies

Virtual healthcare services have accelerated since the pandemic. Growing internet penetration and technological advancements are driving the market further. Meanwhile, analysts are projecting the sector to grow at a compound annual growth rate (CAGR) of over 30% through 2028. Given the sector’s solid growth prospects, I have selected WELL Health Technologies (TSX:WELL) as my first pick. The company focuses on facilitating healthcare practitioners to deliver virtual care and digital patient engagement.

Supported by organic growth and strategic acquisitions, the company posted impressive revenue growth of 127% in the second quarter. Its revenue from virtual services grew by 281% to $47.5 million. When many technology companies struggle to become profitable, WELL Health has reported an adjusted net income of $17.2 million compared to a loss of $1.2 million in the previous year’s quarter.

Additionally, the company has raised its guidance for the third straight quarter, with the management expecting its 2022 revenue to cross $550 million, representing year-over-year growth of over 80%. Moreover, the company’s NTM (next 12-month) price-to-earnings multiple stands at a healthy 15.3, making it an attractive buy. 

goeasy

The second on my list is goeasy (TSX:GSY). The subprime lender has been growing its revenue at a CAGR of over 12% for the last 20 years, while its adjusted EPS (earnings per share) has increased at a rate of 25%. Meanwhile, in the recently reported second quarter, the company’s revenue came in at $252 million, representing a growth of 24% from its previous year’s quarter.

The growth in consumer loans drove the company’s revenue. The record loan originations of $628 million during the quarter increased its loan portfolio to $2.37 billion. The company also witnessed stable credit and payment performance, with the net charge-off rate standing at 9.3%, within the company’s guidance of 8.5-10.5%. Supported by its revenue growth and operating margin expansion, its operating income grew by 52% to $56.1 million.

Amid its strong growth prospects, goeasy’s management expects its loan portfolio to close in on $4 billion in 2024. The management expects its operating margin to improve by 100 basis points yearly while delivering a return on equity of over 22%. So, considering its growth prospects and an attractive NTM price-to-earnings multiple of 9.8, I am bullish on goeasy.

Nuvei

Another stock with tremendous growth potential is Nuvei (TSX:NVEI)(NASDAQ:NVEI), which offers digital payment services to customers across 200 markets. Amid e-commerce growth and growing internet penetration, digital payments are becoming popular. Meanwhile, Markets and Markets projects the segment to grow double digits over the next five years. Given its expanded product offerings, geographical growth, and addition of new alternative payment methods, the company is well positioned to drive its revenue.

After reporting its second-quarter performance, Nuvei’s management has reaffirmed its mid-term growth prospects. The management expects its total volumes and revenue to grow over 30% annually in the medium term, while its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin could cross 50% in the long run. However, amid the steep correction in its stock price, Nuvei’s NTM price-to-earnings multiple has declined to 17.5, which is lower than its historical average. So, I believe Nuvei is an excellent buy at these levels.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool has positions in and recommends Nuvei Corporation. Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »